Whole brain radiotherapy concurrent with capecitabine chemotherapy for patients with brain metastases from post-operative breast cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 813-814,818, 2012.
Article
Dans Chinois
| WPRIM
| ID: wpr-598159
ABSTRACT
Objective To evaluate the efficacy and toxicity of whole brain radiotherapy concurrent with capecitabine for treatment of brain mestastases from breast cancer with post-operative.Methods Fifty patients with brain mestastases from breast cancer with post-operative were randomized into two groups25 patiens were treatend with whole brain radiotherapy concurrent with capecitabine (treatment group) and the other 25 patients were treated with whole brain radiotherapy alone (control group).Radiation dose was 40 Gy in 20 fractions over 4 weeks.Capecitabine was administered concurrently with radiotherapy in escalatiny dose from the 1st day of RT to the end day (850 mg/m2,twice/day).Results The survival rates at 1-and 2-year were 60.0 % (15/25) and 28.0 % (7/25) in treatment group,44.0 % (11/25) and 16.0 % (4/25) in control group (x2 =1.28,1.05,P > 0.05).Toxicities were tolerable.Conclusion Whole brain radiotherapy concurrent with capecitabine was effective and safe in treatment for patients with breat cancer and well-tolerated toxicity.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Essai clinique contrôlé
langue:
Chinois
Texte intégral:
Cancer Research and Clinic
Année:
2012
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS